Literature DB >> 26888565

Cortical contributions to the flail leg syndrome: Pathophysiological insights.

Parvathi Menon1,2, Nimeshan Geevasinga1,2, Con Yiannikas1,3, Matthew C Kiernan1,4, Steve Vucic1,2.   

Abstract

Cortical hyperexcitability has been identified as an intrinsic feature of amyotrophic lateral sclerosis (ALS). Consequently, the aim of the present study was to determine whether cortical hyperexcitability formed the pathophysiological basis for the flail leg syndrome (FL), an atypical ALS variant. Cortical excitability studies were undertaken on 18 FL patients, using the threshold tracking transcranial magnetic stimulation (TMS) technique, and results were compared to healthy controls, upper and lower limb-onset ALS as well as bulbar-onset and the flail arm variant ALS. Results showed that cortical hyperexcitability was a feature of FL and was heralded by a significant reduction of short-interval intracortical inhibition (FL 7.2 ± 1.8%; controls 13.2 ± 0.8%, p <0.01) and cortical silent period (CSP) duration (FL 181.7 ± 10.8ms; controls 209.8 ± 3.4ms; p <0.05) along with an increase in motor evoked potential amplitude (FL 29.2 ± 5.1%; controls 18.9 ± 1.2%, p <0.05). The degree of cortical hyperexcitability was comparable between FL and other ALS phenotypes, defined by site of disease onset. In addition, the CSP duration correlated with biomarkers of peripheral neurodegeneration in FL. In conclusion, cortical hyperexcitability is a feature of the flail leg syndrome, being comparable to other ALS phenotypes. Importantly, cortical hyperexcitability correlates with neurodegeneration, and as such may contribute to the underlying pathophysiology in FL.

Entities:  

Keywords:  Flail leg syndrome; SICI; cortical hyperexcitability

Mesh:

Year:  2016        PMID: 26888565     DOI: 10.3109/21678421.2016.1145232

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  7 in total

Review 1.  Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

Review 2.  Pathophysiological and diagnostic implications of cortical dysfunction in ALS.

Authors:  Nimeshan Geevasinga; Parvathi Menon; P Hande Özdinler; Matthew C Kiernan; Steve Vucic
Journal:  Nat Rev Neurol       Date:  2016-09-23       Impact factor: 42.937

Review 3.  Differentiating lower motor neuron syndromes.

Authors:  Nidhi Garg; Susanna B Park; Steve Vucic; Con Yiannikas; Judy Spies; James Howells; William Huynh; José M Matamala; Arun V Krishnan; John D Pollard; David R Cornblath; Mary M Reilly; Matthew C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-12-21       Impact factor: 10.154

Review 4.  Current view and perspectives in amyotrophic lateral sclerosis.

Authors:  Stéphane Mathis; Philippe Couratier; Adrien Julian; Philippe Corcia; Gwendal Le Masson
Journal:  Neural Regen Res       Date:  2017-02       Impact factor: 5.135

Review 5.  Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques.

Authors:  Mehdi A J van den Bos; Nimeshan Geevasinga; Mana Higashihara; Parvathi Menon; Steve Vucic
Journal:  Int J Mol Sci       Date:  2019-06-10       Impact factor: 5.923

Review 6.  Cortical Excitability across the ALS Clinical Motor Phenotypes.

Authors:  Thanuja Dharmadasa
Journal:  Brain Sci       Date:  2021-05-28

Review 7.  Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis.

Authors:  Aurore Brunet; Geoffrey Stuart-Lopez; Thibaut Burg; Jelena Scekic-Zahirovic; Caroline Rouaux
Journal:  Front Neurosci       Date:  2020-04-29       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.